These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21848905)

  • 21. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-Tetrahidroxyphenyl chlorin): a preliminary study.
    Javaid B
    Lasers Med Sci; 2002; 17(2):135. PubMed ID: 12143833
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat.
    Desroches MC; Bautista-Sanchez A; Lamotte C; Labeque B; Auchère D; Farinotti R; Maillard P; Grierson DS; Prognon P; Kasselouri A
    J Photochem Photobiol B; 2006 Oct; 85(1):56-64. PubMed ID: 16765603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic treatment as a novel approach in the therapy of arthritic joints.
    Hansch A; Frey O; Gajda M; Susanna G; Boettcher J; Bräuer R; Kaiser WA
    Lasers Surg Med; 2008 Apr; 40(4):265-72. PubMed ID: 18412224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin.
    Grosjean P; Savary JF; Mizeret J; Wagnieres G; Woodtli A; Theumann JF; Fontolliet C; Van den Bergh H; Monnier P
    J Clin Laser Med Surg; 1996 Oct; 14(5):281-7. PubMed ID: 9612194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The high photoactivity of m-THPC in photodynamic therapy. Unusually strong retention of m-THPC by RIF-1 cells in culture.
    Ball DJ; Vernon DI; Brown SB
    Photochem Photobiol; 1999 Mar; 69(3):360-3. PubMed ID: 10089829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage selective photodynamic therapy by meta-tetra(hydroxyphenyl)chlorin loaded polymeric micelles: A possible treatment for cardiovascular diseases.
    Wennink JWH; Liu Y; Mäkinen PI; Setaro F; de la Escosura A; Bourajjaj M; Lappalainen JP; Holappa LP; van den Dikkenberg JB; Al Fartousi M; Trohopoulos PN; Ylä-Herttuala S; Torres T; Hennink WE; van Nostrum CF
    Eur J Pharm Sci; 2017 Sep; 107():112-125. PubMed ID: 28679107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
    Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids.
    Marchal S; Fadloun A; Maugain E; D'Hallewin MA; Guillemin F; Bezdetnaya L
    Biochem Pharmacol; 2005 Apr; 69(8):1167-76. PubMed ID: 15794937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro PDT.
    Rogers L; Sergeeva NN; Paszko E; Vaz GM; Senge MO
    PLoS One; 2015; 10(5):e0125372. PubMed ID: 25992651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photophysical origin of the reduced photodynamic therapy activity of temocene compared to Foscan®: insights from theory.
    Alberto ME; Marino T; Quartarolo AD; Russo N
    Phys Chem Chem Phys; 2013 Oct; 15(38):16167-71. PubMed ID: 23985895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
    Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
    Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
    Savary JF; Monnier P; Fontolliet C; Mizeret J; Wagnières G; Braichotte D; van den Bergh H
    Arch Otolaryngol Head Neck Surg; 1997 Feb; 123(2):162-8. PubMed ID: 9046283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis.
    Shikowitz MJ; Abramson AL; Steinberg BM; DeVoti J; Bonagura VR; Mullooly V; Nouri M; Ronn AM; Inglis A; McClay J; Freeman K
    Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):99-105. PubMed ID: 15723939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photophysical studies and in vitro skin permeation/retention of Foscan/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment.
    Primo FL; Bentley MV; Tedesco AC
    J Nanosci Nanotechnol; 2008 Jan; 8(1):340-7. PubMed ID: 18468080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foscan-mediated photodynamic therapy and operation for malignant pleural mesothelioma.
    Schouwink H; Baas P
    Ann Thorac Surg; 2004 Jul; 78(1):388; author reply 388-9. PubMed ID: 15223483
    [No Abstract]   [Full Text] [Related]  

  • 37. Foslip®-based photodynamic therapy as a means to improve wound healing.
    Garrier J; Bezdetnaya L; Barlier C; Gräfe S; Guillemin F; D'Hallewin MA
    Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):321-7. PubMed ID: 22122919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
    Moore CM; Nathan TR; Lees WR; Mosse CA; Freeman A; Emberton M; Bown SG
    Lasers Surg Med; 2006 Jun; 38(5):356-63. PubMed ID: 16392142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells.
    Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L
    Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer.
    Paszko E; Vaz GM; Ehrhardt C; Senge MO
    Eur J Pharm Sci; 2013 Jan; 48(1-2):202-10. PubMed ID: 23159666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.